# Débora S. Bruno

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/debora-s-bruno/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,653 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 20 |
| i10-index | 26 |
| Last Known Institution | City Of Hope National Medical Center |
| OpenAlex ID | https://openalex.org/A5112499105 |
| Works | 99 |

## Researcher papers

- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-1-2020/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)
- [Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study](https://scholariq.org/papers/datopotamab-deruxtecan-versus-docetaxel-for-previously-treated-advanced-or/)
- [Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States](https://scholariq.org/papers/disparities-in-biomarker-testing-and-clinical-trial-enrollment-among-patients/)
- [Impact of bariatric surgery on cancer risk reduction](https://scholariq.org/papers/impact-of-bariatric-surgery-on-cancer-risk-reduction/)
- [Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC).](https://scholariq.org/papers/racial-disparities-in-biomarker-testing-and-clinical-trial-enrollment-in-non/)
- [Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice](https://scholariq.org/papers/sex-differences-in-lung-cancer-treatment-and-outcomes-at-a-large-hybrid-academic/)
- [Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition](https://scholariq.org/papers/small-cell-transformation-of-egfr-mutant-nsclc-treated-with-tyrosine-kinase/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [City Of Hope National Medical Center](https://scholariq.org/institutions/city-of-hope-national-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.